Macrophage inflammatory protein‐2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice
- 1 August 2002
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 80 (4) , 323-327
Abstract
Pseudomonas aeruginosa ocular infection causes extensive corneal neovascularization. The purpose of the present study was to investigate the role of the angiogenic factors macrophage inflammatory protein‐2 (MIP‐2) and vascular endothelial growth factor (VEGF) in the regulation of corneal neovascularization during P. aeruginosa ocular infection. After administering anti‐MIP‐2 antibody or control antibody, mouse corneas were challenged with P. aeruginosa. The expression of MIP‐2 and VEGF was detected using an ELISA from ocular homogenates. Corneal neovascularization was examined by histology. The cellular sources of MIP‐2 and VEGF were identified by immunohistochemistry. In addition, protein expression of MIP‐2 and VEGF in isolated corneas was measured to determine the ability of the cornea to produce these two mediators. Results showed that the expression of MIP‐2 and VEGF was significantly (P < 0.05) elevated after bacterial infection, and high levels of these two mediators paralleled the extensive corneal neovascularization seen at later stages of the infection. Anti‐MIP‐2 antibody treatment resulted in a significant (P < 0.05) reduction in VEGF expression and in corneal neovascularization. Both corneal resident cells and infiltrating neutrophils had the ability to produce MIP‐2 and VEGF after stimulation. The present study demonstrates that both MIP‐2 and VEGF are important mediators in the regulation of corneal neovascularization caused by P. aeruginosa infection, and that MIP‐2 regulates the production of VEGF.Keywords
Funding Information
- Australian Federal Governmentthrough the Cooperative Research Centre
This publication has 15 references indexed in Scilit:
- Contribution of Vascular Endothelial Growth Factor in the Neovascularization Process during the Pathogenesis of Herpetic Stromal KeratitisJournal of Virology, 2001
- Control of Stromal Keratitis by Inhibition of NeovascularizationThe American Journal of Pathology, 2001
- Chemokines and angiogenesisCurrent Opinion in Rheumatology, 2001
- Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid jointArthritis & Rheumatism, 2001
- Expression of Interleukin-8 Correlates with Angiogenesis, Tumorigenicity, and Metastasis of Human Prostate Cancer Cells Implanted Orthotopically in Nude MiceNeoplasia, 2001
- Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non–Small-Cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2000
- TNF‐α production in the cornea in response to Pseudomonas aeruginosa challengeImmunology & Cell Biology, 1999
- Vascular Endothelial Growth Factor Upregulates the Expression of Matrix Metalloproteinases in Vascular Smooth Muscle CellsCirculation Research, 1998
- Different strains ofPseudomonas aeruginosaisolated from ocular infections or inflammation display distinct corneal pathologies in an animal modelCurrent Eye Research, 1998
- Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.Proceedings of the National Academy of Sciences, 1993